10 pharmaceutical technology transfer experts
These ten professionals have held technology transfer roles at pharmaceutical companies, with titles such as Technology Transfer Manager and Head of Global Tech Transfer. A reader can learn how pharmaceutical companies transfer processes and products into manufacturing sites.
Professionals to explore
Barbara Gallego Exposito
LinkedInExperience: Universal Farma Site Associate Director · Chemo
Former Technology Transfer Manager (2020–2026) and Technology Transfer Team Leader (2014–2020) at Chemo, and Universal Farma Site Associate Director at Chemo since 2026. For the manager role, the profile describes leading end-to-end technology transfer projects for pharmaceutical products and manufacturing processes across internal sites, external partners and Contract Manufacturing Organizations (CMOs).
Is this you? Claim your profile and get paid for calls.
Carin M. Kahr
LinkedInExperience: Former Head of Global Tech Transfer · Biogen
Former Head of Global Tech Transfer (2022–2023) and Senior Manager, Tech Transfer (2020–2022) at Biogen, and Senior Director, MSAT at Veloxis Pharmaceuticals, Inc. since 2026. The profile describes expertise in process development, manufacturing sciences and process engineering, and lists Associate Director, MSAT at AskBio Inc. (2023–2026).
Is this you? Claim your profile and get paid for calls.
Catherine Watkins
LinkedInExperience: Head of Global MSAT Tech Transfer and Program Management · Takeda
Head of Global MSAT Tech Transfer and Program Management at Takeda since 2026, with Global Head of Product Quality & LCM, Biologics Operating Unit at Takeda also listed since 2025. The profile describes leading enterprise governance and execution for complex technology transfers across all modalities, from development through commercialization.
Is this you? Claim your profile and get paid for calls.
Cecilia Goncalves
LinkedInExperience: Analytical Transfer Leader · Sanofi
Analytical Transfer Leader at Sanofi since 2022, a role the profile places within the Tech Transfer, MSAT department and describes as responsible for technical process and analytical transfer projects, including defining and leading analytical transfer strategy with sending and receiving units. The profile also lists Product and Process Specialist - seed and international Influenza vaccine at Sanofi (2019–2022).
Is this you? Claim your profile and get paid for calls.
Glenn Loos
LinkedInExperience: Technology Tranfer Lead · Sanofi
Technology Tranfer Lead at Sanofi since 2025, a role the profile describes as overseeing the transfer of processes and technologies from development to internal manufacturing sites or from Sanofi to CMOs. The profile also lists MSAT Process Engineer - Tech Transfer (2018–2019) and MSAT senior process engineer - Downstream Purification (2019–2025) at Sanofi.
Is this you? Claim your profile and get paid for calls.
Kevin Bai
LinkedInExperience: Technology Transfer Leader - MSAT · Sanofi
Technology Transfer Leader - MSAT at Sanofi since 2024. The profile describes hands-on experience and knowledge of CMC drug substance and drug product development, tech transfer and the approval process in the pharma and biotech industry, and lists Associate Director - Process Development at Aurinia Pharmaceuticals Inc. (2022–2024).
Is this you? Claim your profile and get paid for calls.
Litza Montalvan
LinkedInExperience: MSAT Technology Transfer Strategy Lead · Johnson & Johnson Innovative Medicine
MSAT Technology Transfer Strategy Lead at Johnson & Johnson Innovative Medicine since 2025. The profile also lists Technical Operations Senior Manager - Site Lead at The Janssen Pharmaceutical Companies of Johnson & Johnson (2015–2024), Manufacturing Manager there (2013–2015) and Associate Director Strategic Planning at AbbVie (2024–2025).
Is this you? Claim your profile and get paid for calls.
Moon‐Sun Jang
LinkedInExperience: MSAT Synthetic DP APAC Sites Director · Johnson & Johnson Innovative Medicine
Former Global MSAT - Technical Launch Integrator (Tech transfer of Protein DP and vaccines) at Johnson & Johnson Innovative Medicine (2017–2021), and MSAT Synthetic DP APAC Sites Director there since 2026. The profile cites strength in project management and technology transfer and end to end experience of injections (protein DP) from sourcing decision to technology transfer, and lists Site MSAT lead - Associate Director (2021–2026).
Is this you? Claim your profile and get paid for calls.
Thomas Hadamzyk
LinkedInExperience: Director Global MSAT Strategy & Operations Product Supply · BioNTech SE
Former Associate Director Technology Transfer Product Supply at BioNTech SE (2022–2024), and Director Global MSAT Strategy & Operations Product Supply at BioNTech SE since 2024. The profile also lists Advanced Expert Transfer&Launch (MSAT) Pharma Global Technical Operations at Roche (2020–2022) and describes technology transfer and manufacturing strategy roles for DS and DP manufacturing across mRNA, CGT and biologics.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Match the person's modality to yours, since biologics, vaccines, cell and gene therapies and small molecules transfer in different ways. For hands-on questions about running a single transfer, favor someone in a transfer lead role, and for questions about governing a portfolio of transfers across sites, favor someone with a global or head-of-function scope.
Questions to take into the conversation
- 01What do you need in place before a technology transfer starts, and what most often gets missed?
- 02How do you divide responsibilities between the sending and receiving sites, and how do you resolve disagreements?
- 03How do you decide when a transfer is complete and the receiving site is ready for validation batches?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.